Olberg D - Search Results

1

Synthesis and preclinical evaluation of a selective MET kinase positron emission tomography tracer.

Lien VT, Hauge E, Nuruddin S, Klaveness J, Olberg DE. Lien VT, et al. Among authors: olberg de. J Labelled Comp Radiopharm. 2023 Dec;66(14):452-460. doi: 10.1002/jlcr.4066. Epub 2023 Oct 22. J Labelled Comp Radiopharm. 2023. PMID: 37867318

2

A new automated and putatively versatile synthesis of the PSMA-ligand derivative [¹⁸F]DCFPyL using the FASTlab^TM synthesizer.

Hoareau R, Bach-Gansmo T, Cumming P, Olberg DE. Hoareau R, et al. Among authors: olberg de. EJNMMI Radiopharm Chem. 2022 May 4;7(1):10. doi: 10.1186/s41181-022-00157-0. EJNMMI Radiopharm Chem. 2022. PMID: 35507241 Free PMC article.

3

Preclinical evaluation of [¹⁸F]cabozantinib as a PET imaging agent in a prostate cancer mouse model.

Lien VT, Celen S, Nuruddin S, Attili B, Doumont G, Van Simaeys G, Bormans G, Klaveness J, Olberg DE. Lien VT, et al. Among authors: olberg de. Nucl Med Biol. 2021 Feb;93:74-80. doi: 10.1016/j.nucmedbio.2020.12.002. Epub 2020 Dec 23. Nucl Med Biol. 2021. PMID: 33422771

4

Fluorine-18-Labeled Antibody Ligands for PET Imaging of Amyloid-β in Brain.

Syvänen S, Fang XT, Faresjö R, Rokka J, Lannfelt L, Olberg DE, Eriksson J, Sehlin D. Syvänen S, et al. Among authors: olberg de. ACS Chem Neurosci. 2020 Dec 16;11(24):4460-4468. doi: 10.1021/acschemneuro.0c00652. Epub 2020 Nov 25. ACS Chem Neurosci. 2020. PMID: 33236886 Free PMC article.

5

Correction: Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation.

Lien VT, Kristiansen MK, Pettersen S, Haugen MH, Krauss S, Olberg DE, Waaler J, Klaveness J. Lien VT, et al. Among authors: olberg de. RSC Adv. 2020 Jan 31;10(9):4927. doi: 10.1039/d0ra90007a. eCollection 2020 Jan 29. RSC Adv. 2020. PMID: 35503286 Free PMC article.

6

A Survey of Molecular Imaging of Opioid Receptors.

Cumming P, Marton J, Lilius TO, Olberg DE, Rominger A. Cumming P, et al. Among authors: olberg de. Molecules. 2019 Nov 19;24(22):4190. doi: 10.3390/molecules24224190. Molecules. 2019. PMID: 31752279 Free PMC article. Review.

7

Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation.

Lien VT, Kristiansen MK, Pettersen S, Haugen MH, Olberg DE, Waaler J, Klaveness J. Lien VT, et al. Among authors: olberg de. RSC Adv. 2019 Nov 13;9(63):37092-37100. doi: 10.1039/c9ra08954c. eCollection 2019 Nov 11. RSC Adv. 2019. PMID: 35539091 Free PMC article.

8

Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier.

Aasen SN, Espedal H, Holte CF, Keunen O, Karlsen TV, Tenstad O, Maherally Z, Miletic H, Hoang T, Eikeland AV, Baghirov H, Olberg DE, Pilkington GJ, Sarkar G, Jenkins RB, Sundstrøm T, Bjerkvig R, Thorsen F. Aasen SN, et al. Among authors: olberg de. Mol Cancer Ther. 2019 Nov;18(11):2171-2181. doi: 10.1158/1535-7163.MCT-19-0160. Epub 2019 Aug 29. Mol Cancer Ther. 2019. PMID: 31467182

9

Design, synthesis and biological evaluation of 6-substituted quinolines derived from cabozantinib as c-Met inhibitors.

Lien VT, Pettersen S, Haugen MH, Olberg DE, Maelandsmo GM, Klaveness J. Lien VT, et al. Among authors: olberg de. Arch Pharm (Weinheim). 2019 Sep;352(9):e1900101. doi: 10.1002/ardp.201900101. Epub 2019 Aug 15. Arch Pharm (Weinheim). 2019. PMID: 31414521

10

Synthesis of protectin D1 analogs: novel pro-resolution and radiotracer agents.

Tungen JE, Aursnes M, Ramon S, Colas RA, Serhan CN, Olberg DE, Nuruddin S, Willoch F, Hansen TV. Tungen JE, et al. Among authors: olberg de. Org Biomol Chem. 2018 Sep 19;16(36):6818-6823. doi: 10.1039/c8ob01232f. Org Biomol Chem. 2018. PMID: 30204204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page